NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
50 hedge funds and large institutions have $51M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$5.98M | |
| 2 | +$1.1M | |
| 3 | +$948K | |
| 4 |
GC
Greenlight Capital
New York
|
+$940K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$733K |
Top Sellers
| 1 | -$3.68M | |
| 2 | -$2.58M | |
| 3 | -$756K | |
| 4 |
Two Sigma Advisers
New York
|
-$216K |
| 5 |
BlackRock
New York
|
-$200K |